Patents by Inventor Xavier MONTAGUTELLI

Xavier MONTAGUTELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid vaccine against the SARS-CoV-2 coronavirus
    Patent number: 11969467
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Grant
    Filed: September 12, 2023
    Date of Patent: April 30, 2024
    Assignee: INSTITUT PASTEUR
    Inventors: Etienne Simon-Loriere, Matthieu Prot, Xavier Montagutelli
  • Nucleic acid vaccine against the SARS-CoV-2 coronavirus
    Patent number: 11964013
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Grant
    Filed: September 12, 2023
    Date of Patent: April 23, 2024
    Assignee: INSTITUT PASTEUR
    Inventors: Etienne Simon-Loriere, Matthieu Prot, Xavier Montagutelli
  • Nucleic acid vaccine against the SARS-CoV-2 coronavirus
    Patent number: 11911462
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Grant
    Filed: July 12, 2023
    Date of Patent: February 27, 2024
    Assignee: INSTITUT PASTEUR
    Inventors: Etienne Simon-Loriere, Matthieu Prot, Xavier Montagutelli
  • NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS
    Publication number: 20240042014
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Application
    Filed: September 12, 2023
    Publication date: February 8, 2024
    Inventors: Etienne SIMON-LORIERE, Matthieu PROT, Xavier MONTAGUTELLI
  • NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS
    Publication number: 20240024462
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Application
    Filed: September 12, 2023
    Publication date: January 25, 2024
    Inventors: Etienne SIMON-LORIERE, Matthieu PROT, Xavier MONTAGUTELLI
  • NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS
    Publication number: 20240000922
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Application
    Filed: July 12, 2023
    Publication date: January 4, 2024
    Inventors: Etienne SIMON-LORIERE, Matthieu PROT, Xavier MONTAGUTELLI
  • Nucleic acid vaccine against the SARS-CoV-2 coronavirus
    Patent number: 11759516
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: September 19, 2023
    Assignee: INSTITUT PASTEUR
    Inventors: Etienne Simon-Loriere, Matthieu Prot, Xavier Montagutelli
  • NUCLEIC ACID VACCINE AGAINST THE SARS-CoV-2 CORONAVIRUS
    Publication number: 20220401550
    Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
    Type: Application
    Filed: August 11, 2022
    Publication date: December 22, 2022
    Inventors: Etienne SIMON-LORIERE, Matthieu PROT, Xavier MONTAGUTELLI